The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain ...

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence ...

Revolution Medicines $2B fundraise, Structure's new hire hints at acquisition efforts, and more Readout biotech news ...

The DOJ’s Weaponization Working Group — a purportedly apolitical effort to weed out politically motivated actions within the ...

His repeated ER visits weren’t about individual failure; they reflected structural barriers — transportation, access, work ...

New AI tools could screen existing CT scans to asses risk for heart disease. But, who'll pay for it, and will it improve ...

These sides aren't talking to each other. And there's a lot riding on it”: the podcast trying to bridge MAHA and public ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Former Sen. Ben Sasse gives a glimpse of what it's like to be a participant in an tough but promising new drug for pancreatic ...

Yesterday, we got highly promising results from a trial of Revolution Medicines’ pancreatic cancer pill, showing that ...

The director of WHO's Eastern Mediterranean region is weighing whether to run to be the next director-general at a time of ...

The FDA told more than 2,200 companies and researchers that they are required to report clinical trial results, or they may ...